Abstract Migraine is a painful and debilitating disorder with a significant genetic component. Steroid hormones, in particular estrogen, have long been considered to play a role in migraine, as variations in hormone levels are associated with migraine onset in many sufferers of the disorder. Steroid hormones mediate their activity via hormone receptors, which have a wide tissue distribution. Estrogen receptors have been localized to the brain in regions considered to be involved in migraine pathogenesis. Hence it is possible that genetic variation in the estrogen receptor gene may play a role in migraine susceptibility. This study thus examined the estrogen receptor 1 (ESRa) gene for a potential role in migraine patho-genesis and susceptibility. A population-based cohort of 224 migraine sufferers and 224 matched controls were genotyped for the G594A polymorphism located in exon 8 of the ESR1 gene. Statistical analysis indicated a significant difference between migraineurs and non-migraineurs in both the allele frequencies (P=0.003) and genotype distributions (P=0.008) in this sample. An independent follow-up study was then undertaken using this marker in an additional population-based cohort of 260 migraine sufferers and 260 matched controls. This resulted in a significant association between the two groups with regard to allele frequencies (P=810 6 ) and genotype distributions (P=410 5 ). Our findings support the hypothesis that genetic variation in hormone receptors, in particular the ESR1 gene, may play a role in migraine.
Introduction
Migraine is a genetically complex disease with a multifactorial mode of inheritance [1, 2] . It has a high prevalence, with approximately 18% of women and 6% of men suffering from the disorder [3] . Migraine is characterized by severe head pain with associated nausea, emesis, photophobia, phonophobia, and neurological disturbances. The International Headache Society (IHS) has classified various types of migraine according to their clinical features [4] . The two main subtypes of migraine are migraine without aura (MO), occurring in~70-75% of migraineurs, and migraine with aura (MA) which occurs in~25% of migraineurs [4] . Some people experience both types of attack in their lives [5] . While the precise pathogenesis of migraine is unknown, it is widely accepted that short-term alterations in neuronal activity occur in relation to the attack, along with temporary changes in the cerebral vasculature. Trigeminal nerve activation is also considered pivotal to progression of a migraine attack [6] .
There is significant evidence to indicate that the fluctuating hormones of the ovarian cycle are specific migraine triggers [7, 8] , although the precise role of hormones in the pathogenesis of migraine is yet to be established. To date, studies have focused on the hormonal milieu, in particular estrogen. The currently recognized mechanism of hormonally triggered migraine is estrogen withdrawal. However, this theory is based on empirical evidence that attacks can be prevented by artificially stabilizing hormone levels [9] .
Steroid hormones exert their effects via a cognate receptor. The classic mode of action of steroid hormone receptors is as ligand-activated transcription factors, regulating gene expression via interaction with hormone response elements in the promoter region of sensitive genes. Recent research has also demonstrated non-genomic effects of steroid hormone receptors, resulting in rapid effects activated via intracellular second messenger systems [10] . Furthermore, there is evidence to indicate that steroid hormone receptors can be activated in the absence of hormones [11] . Given the putative role of hormones in migraine, and the relationship between steroid hormones and their receptors, we postulated that genes encoding hormone receptors represent likely candidates for migraine studies.
ESR1 is located on chromosome 6q25.1. It has eight exons [12] , and is over 295 kilobases in size [13] . ESR1 is expressed in various human brain regions including the hypothalamus, limbic system, hippocampus, cortices of the temporal lobe, and the brainstem [14] . It is expressed in serotonin neurons of some species [15] . In addition to alternative splicing mechanisms, different promoters are used to regulate ESR1 in distinct neuronal populations [14] . Along with its role in target gene transcription, ligand-activated ESR1 has rapid effects on neuronal excitability via second messenger systems, resulting in a range of cellular effects including changes in calcium currents and activation of endothelial nitric oxide synthase [11, 16, 17] . As changes in neuronal excitability have been implicated in migraine pathogenesis, we hypothesized that genetic variation in ESR1 may impact on expression or function, in turn influencing migraine susceptibility. To our knowledge, no published study exists on the potential role of this gene in migraine. Our pilot study has investigated a common synonymous polymorphism located in exon 8 of the ESR1 gene (NCBI mRNA ref seq MN_000125) [18] . This polymorphism, first described by Roodi et al. (1985) [19] , occurs in codon 594 of exon 8 and consists of a guanine to adenine change at nucleotide 2014 (SNP rs 2228480). This polymorphism has previously shown an association with breast cancer, a disease in which complex hormonal influences are considered to play a role [20] . Given the putative role of hormones in migraine, we chose this polymorphism as a candidate for our current investigations. The investigation was undertaken using a population-based case-control approach. Due to past problems with non-replication of positive associations, we performed an additional study on an independent population-based cohort using the same marker.
Materials and methods

Study population
Research was approved by the Griffith University Ethics Committee for experimentation on human subjects. All 1,150 participants of the study gave informed consent prior to participation. All participants were interviewed, and completed a detailed questionnaire providing information including personal and family medical history, migraine symptoms, age of onset, frequency, severity, and treatment as previously described [21, 22] . This questionnaire revealed that 78% of individuals in the migraine group had a known family history of migraine. Migraineurs were diagnosed by a clinical neurologist as having either MA or MO based strictly on the widely accepted criteria specified by the IHS [4] . The first study population was comprised of 275 migraineurs and 275 unrelated control individuals. The controls were matched for sex, age (€5 years), and ethnicity (Caucasian) to avoid the potential bias of population stratification, and were recruited in parallel at a similar time and geographical location (East Coast of Australia) as the case group. The follow-up second study population consisted of 300 migraineurs similarly diagnosed and matched with 300 controls. All participants provided a blood sample from which DNA was extracted by a modification of the salting out method used by Miller et al. [23] .
Genotyping
Genotyping for the ESR1 G594A marker was undertaken by polymerase chain reaction (PCR) and restriction enzyme digestion. Oligonucleotide primers used were those previously described by Curran et al. [20] 
Statistical analysis
Genotype data and allele frequencies were compared between the two populations using standard chi-squared analysis. Only when results were available from both matched pairs, i.e., migraine-affected and age-and sex-matched controls, were they included in the genotypic analyses. Odds ratios (OR) and 95% confidence intervals (CI) were calculated. Due to multiple testing, the Bonferroni cor- Lane 8 shows 227-, 129-, and 98-base pair fragments of a heterozygote rection for five tests was applied, which set the level of significance at 0.01 (i,e., 0.05/5) [24] . All genotype frequencies were tested for Hardy-Weinberg equilibrium.
Results
Statistical analysis revealed a significant difference between genotyped migraineurs and the matched control group with regard to allele frequencies (P=0.003) and genotype frequencies (P=0.008). Results of comparisons between male case and control groups (allele frequency P=0.034, genotype frequency P=0.046) and female case and control groups (allele frequency P=0.032, genotype frequency P=0.064) indicated that no significant gender effect was evident. Furthermore, the association was seen in both subgroups, MA (allele frequency P=0.013, genotype frequency P=0.025) and MO (allele frequency P=0.019, genotype frequency P=0.007). Consequently, the significant association seen in the case-control analysis occurred similarly in both males and females, and in the MA and MO subgroups. Results are displayed in Table 1 . The follow-up independent study also revealed a significant difference between genotyped migraineurs and the matched control group with regard to allele frequencies ( P=810 6 ) and genotype frequencies ( P=410 5 ). This significant association occurred in females (allele frequency P=310
6
, genotype frequency P=210
5
) and in the MA subgroup (allele frequency P=110 6 , genotype frequency P=710 6 ). Although the association did not occur in males (allele frequency P=0.717, genotype frequency P=0.127) and the MO subgroup (allele frequency P=0.529, genotype frequency P=0.818), this may be due to small numbers in these subgroups (males n=36, MO n=39). Alternatively, estrogen and its receptor may play a lesser role in male migraineurs. Results are displayed in Table 2 . Allele frequencies in both study populations did not deviate from Hardy-Weinberg equilibrium (P=0.14, P=0.88), and each independent sample cohort showed similar frequencies in the case and control groups. Internal controls using random repeat samples and negative controls were used to confirm genotypes and to exclude the potential for genotyping errors, which in our hands have been estimated to be <5%. Only when results for both of a matched pair were obtained, were they included in the analysis. Results of OR calculations based upon the Mantel Haenszel method of combining the datasets [22] In summary, we performed association analyses in two independent study populations. Results of these studies, which have remained significant after we have applied a Bonferroni correction for multiple testing (a=0.01), provide evidence for association of the ESR1 G594A polymorphism with migraine susceptibility.
Discussion
Migraine is considered a genetically complex disorder showing strong familial aggregation. A higher concordance in monozygotic twins than dizygotic twins indicates a strong genetic component along with complex inheritance [25] . Approximately 50% of susceptibility is attributed to multiple genes, while the balance is attributed to environmental factors [26] . Although the genetic basis for migraine is largely unknown, investigations of various genes involved in key biological pathways have been undertaken. Results to date have been mixed, although this may be attributed in part to the heterogeneous nature of the disorder. Current understanding of migraine is that a number of genes and/or environmental factors may each contribute to an individual's migraine susceptibility [26] .
Steroid hormones, in particular estrogen, have long been considered to play a role in migraine pathogenesis. The present study considered that this role could be related to or exacerbated by variation in the estrogen receptor gene. We have conducted a case-control association study to investigate the estrogen receptor 1 gene as a candidate in migraine susceptibility. This method is considered useful for investigating complex diseases [27] and for detecting susceptibility genes of modest effect [28] . The study tested two large carefully matched case-control populations for an ESR1 exon 8 single nucleotide polymorphism. Results of this study have indicated a positive association of an ESR1 exon 8 polymorphism with migraine in two independent cohorts. This positive association was seen equally in all subgroups in the initial study group and in the female and MA subgroups in the followup group. Lack of association in males may have been related to the limited number of males in the second population. However, it is also possible that hormonal factors may play a different role in the two genders in migraine, and estrogen and its receptor may play a lesser role in male migraineurs.
Although this marker showed significant differences in allele frequencies in the two test versus control populations, association studies by virtue of their design do not determine whether it is the marker itself or a variant in linkage disequilibrium that is responsible for the association. Further genetic and functional analyses will be needed to determine the causal mechanism for our detected estrogen receptor association. It is possible that other polymorphisms and mutations in this gene may be associated with migraine, in particular those in linkage disequilibrium with this particular marker. Previous population genetics studies performed in our laboratory have shown that markers in exon 1 and exon 4 were not in linkage disequilibrium with the exon 8 variant [20] . This information suggests that the migraine susceptibility haplotype is specific to the 3 0 region of the ESR1 gene. To our knowledge this is the first study to report an association of a hormone-related gene variant with migraine and these data suggest that the estrogen receptor gene may be an integral player in mechanisms that are relevant to migraine pathogenesis.
Steroid hormones, via their receptors, have many well-known effects on the central nervous system, particularly in relation to sexual differentiation and reproductive function. New information is emerging indicating a much-wider range of effects than previously understood. Furthermore, these effects have the potential to impact on factors involved in migraine pathogenesis. Estradiol can exert behavioral and electrophysiological effects by binding to neuronal membranes, in particular the central serotonergic and opioid neurons. This mechanism may lead to a disturbance of pain perception [29] . According to animal models, sex steroid hormones may also cause changes in regions involved in the neurovascular headache pathway [30] . Estrogen changes in the rat have been associated with altered mRNA expression in sensory neurons [31] , while estrogen injections appear to alter the size of the receptive area of the trigeminal mechanoreceptors in rats [32] .
A further possible explanation for the role of estrogen receptor in migraine is its influence on calcium channels [10] . Due to the discovery of mutations in the CACNA1A calcium channel gene in familial hemiplegic migraine, a rare subtype of migraine, a role for calcium channels and calcium homeostasis in the pathogenesis of common migraine is also possible. Calcium and other ion channels are significant factors in the mechanism of neurotransmitter release and cortical spreading depression [33] , thus impaired function of calcium channels and calcium homeostasis could trigger an attack. Furthermore, an altered density of calcium channels could result in excitation of the periaqueductal grey, raphe nuclei, or locus coeruleus neurons that are considered to be in the region responsible for initiation of migraine attacks [33] .
L-type calcium channels are one of the main pathways of intercellular calcium entry in the brain. Johnson et al. [34] demonstrated in an animal model that the density of cardiac L-type calcium channels is regulated by the estrogen receptor, while Mermelstein et al. [35] demonstrated that estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. A further consideration is that ESR can mediate changes in vascular tone. Chen et al. [17] demonstrated that ESR1 mediates the non-genomic activation of endothelial nitric oxide synthase, causing the rapid dilation of blood vessels. Furthermore, the observed response was evident at concentrations well below those found in normal cycling women. Obviously these hypotheses would require extensive analysis, as estrogen/ESR action is understood to be tissue specific. Nevertheless they demonstrate potential mechanisms whereby genetic variation in the estrogen receptor gene could have an impact on mechanisms that may be crucial to migraine pathogenesis.
